PubMedCrossRef 18. Jeggo P, Lobrich M: Radiation-induced DNA damage responses. Radiat
Prot Dosim 2006, 122:124–127.CrossRef 19. Chistiakov DA, Voronova NV, Chistiakov PA: Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer selleckchem patients. Acta Oncologica 2008, 47:809–824.PubMedCrossRef 20. Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, Hall J: Polymorphisms in the DNA Repair Gene XRCC1, NU7441 Breast Cancer Risk, and Response to Radiotherapy. Cancer Epidemiol Biomarkers Prev 2003, 12:1168–1174.PubMed 21. Mango Mangoni M, Bisanzi S, Carozzi F, Sani C, Biti G, Livi L, Barletta E, Costantini AS, Gorini G: Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys 2011, 81:52–58.CrossRef see more 22. Popanda O, Tan XL, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude
J: Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Cancer Epidemiol Biomarkers Prev 2006, 15:1048–1050.PubMedCrossRef 23. Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Ambrosone CB: Association between polymorphisms in the DNA repair genes,XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer SB-3CT patients. Clin Cancer Res 2005, 11:4802–4809.PubMedCrossRef 24. Travis EL: Genetic susceptibility to late normal tissue injury. Semin Radiat Oncol 2007, 17:14.CrossRef 25. Morgan JL, Holcomb TM, Morrissey RW: Radiation reaction in ataxia telangiectasia. Am J Dis Child 1968, 116:557–558.PubMed 26. Iaccarino G, Pinnaro P, Landoni V, Marzi S, Soriani A, Giordano C, Arcangeli S, Benassi M, Arcangeli G: Single fraction partial breast irradiation in prone position. J Exp Clin Cancer Res 2007, 26:543–552.PubMed 27. Bruzzaniti V, Abate A, Pedrini M, Benassi M, Strigari L: IsoBED: a tool for automatic calculation of biologically
equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique. J Exp Clin Cancer Res 2011, 30:52.PubMedCrossRef 28. Creton G, Benassi M, Di Staso M, Ingrosso G, Giubilei C, Strigari L: The time factor in oncology: consequences on tumour volume and therapeutic planning. J Exp Clin Cancer Res 2006, 25:557–573.PubMed 29. Cividalli A, Creton G, Ceciarelli F, Strigari L, Tirindelli Danesi D, Benassi M: Influence of time interval between surgery and radiotherapy on tumor regrowth. J Exp Clin Cancer Res 2005, 24:109–116.PubMed 30. Strigari L, D’Andrea M, Abate A, Benassi M: A heterogeneous dose distribution in simultaneous integrated boost: the role of the clonogenic cell density on the tumor control probability.